On Friday May 17, just before the start of the annual congress of the American Thoracic Society (ATS) in Dallas, the second meeting of the Respiratory Innovation summit (RIS) takes place.
The RIS is intended to engage top investors, industry leaders and key opinion leaders to discuss key-topics in the translation of concepts to therapeutics, smart tools and devices for treatment of pulmonary diseases.
The CEO of FLUIDDA, Inc, Jan de Backer, MSc, PhD, MBA will be chairing a very interesting session titled:
“How Artificial Intelligence will impact Respiratory Diagnosis and Treatment”.
If you want to participate this very interesting meeting, registration is still open.